Ascorbate Supplementation in Kidney Failure
Ascorbate supplementation in Kidney failure and effect on quality of life
The Canberra Hospital
100 participants
Jun 1, 2008
Interventional
Conditions
Summary
The primary aim of this study is to discover if giving patients with severe kidney failure ascorbate (vitamin C) reduces symptoms that are common to both renal failure and ascorbate deficiency. It is known that low ascorbate levels are common in patients with severe kidney failure, and that symptoms of scurvy (ascorbate deficiency) and of kidney failure (uraemic syndrome) overlap. There is however no consensus on whether ascorbate supplementation is beneficial in patients with severe kidney disease and there are concerns that supplementation may cause adverse effects. This study would significantly improve clinical care, by examining the benefits and adverse outcomes of supplementation.
Eligibility
Inclusion Criteria1
- Receiving maintenance dialysis treatment OR estimated Modification of Diet in Renal Diseases Glomerular Filtration Rate (MDRD GFR) of less than 20ml/min
Exclusion Criteria6
- Life expectancy less than 3 months
- Primary hyperoxaluria
- Clinically unstable
- Unable to provide informed consent
- Unwilling to cease non study ascorbate containing supplements
- Not fluent in English
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral ascorbic acid 250mg three times a week for 3 months from when subject is first enrolled into the study
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000016336